{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:37:55Z","timestamp":1776353875260,"version":"3.51.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Synthetic cathinones constitute the second largest groups of new psychoactive substances (NPS), which are especially popular among adolescents and young adults. Due to their potential toxicity, the recreational use of these NPS constitute a serious worldwide public health problem. However, their fast appearance in the market renders the continuous updating of NPS information highly challenging for forensic authorities. The unavailability of pharmacokinetic data for emerging NPS is critical for forensic and clinical verifications. With the ultimate goal of having a proactive approach towards the NPS issue, high resolution mass spectrometry was used in the current work to assess preliminary pharmacokinetic data for 8 selected cathinones: 4 reported substances (<jats:bold>4-CIC<\/jats:bold>, <jats:bold>3-CMC<\/jats:bold>, <jats:bold>4-CMC<\/jats:bold> and <jats:bold>4-MEAP<\/jats:bold>) and 4 previously unreported ones (<jats:bold>3-CIC<\/jats:bold>, <jats:bold>4-MDMB<\/jats:bold>, <jats:bold>4-MNEB<\/jats:bold> and <jats:bold>4-MDMP<\/jats:bold>) for which the emergence on the NSP market is expected to be eminent, were also included in this study. Based on the calculation of pharmacokinetic parameters, half-life and intrinsic clearance, <jats:bold>4-CMC<\/jats:bold> and <jats:bold>4-MDMB<\/jats:bold> are low and high clearance compounds, respectively, and all the remaining cathinones included in this study are intermediate clearance compounds. This fact anticipates the key role of metabolites as suitable biomarkers to extend detection windows beyond those provided by the parent cathinones. Reduction of the keto group and hydroxylation on the alkyl chains were the common metabolic pathways identified for all cathinones. However, the relative importance of these metabolic transformations is dependent on the cathinone substituents. The glucuronic acid conjugation to metabolites stemming for keto group reduction constituted the sole Phase II transformation identified. To our knowledge, this study constitutes the first metabolite profiling of the already reported synthetic cathinones <jats:bold>4-CIC<\/jats:bold>, <jats:bold>3-CMC<\/jats:bold> and <jats:bold>4-CMC<\/jats:bold>. Noteworthy is the fact that <jats:bold>3-CMC<\/jats:bold> accounts for almost a quarter of the quantity of powders seized during 2020. The analytical methods developed, and the metabolites characterized, are now available to be included in routine screening methods to attest the consumption of the 8 cathinones studied.<\/jats:p>","DOI":"10.3389\/fphar.2023.1145140","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T05:36:55Z","timestamp":1679636215000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Metabolic stability and metabolite profiling of emerging synthetic cathinones"],"prefix":"10.3389","volume":"14","author":[{"given":"Rita P.","family":"Lopes","sequence":"first","affiliation":[]},{"given":"Raquel A.","family":"Ferro","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Milhazes","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Figueira","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Caldeira","sequence":"additional","affiliation":[]},{"given":"Alexandra M. M.","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Gaspar","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/DTA.2218","article-title":"Analytical characterization of three cathinone derivatives, 4-MPD, 4F\u2013PHP and bk-EPDP, purchased as bulk powder from online vendors","volume":"10","author":"Apirakkan","year":"2018","journal-title":"Drug Test. Anal."},{"key":"B2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/164_2018_178","article-title":"Neuropharmacology of synthetic cathinones","volume":"252","author":"Baumann","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11419-019-00486-x","article-title":"Case report on two-cathinones abuse: MPHP and N-ethyl-4\u2032methylnorpentedrone, with a fatal outcome","volume":"38","author":"Benedicte","year":"2020","journal-title":"Forensic Toxicol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"110659","DOI":"10.1016\/J.FORSCIINT.2020.110659","article-title":"Fatal intoxication involving 4-methylpentedrone (4-MPD) in a context of chemsex","volume":"319","author":"Cartiser","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1208\/s12248-009-9103-6","article-title":"Prediction of hepatic clearance in human from in vitro data for successful drug development","volume":"11","author":"Chiba","year":"2009","journal-title":"AAPS J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/03602532.2019.1620763","article-title":"Pharmacokinetic and pharmacodynamic of bupropion: Integrative overview of relevant clinical and forensic aspects","volume":"51","author":"Costa","year":"2019","journal-title":"Drug Metab. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/03602532.2016.1188937","article-title":"Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases","volume":"48","author":"Ellefsen","year":"2016","journal-title":"Drug Metab. Rev."},{"key":"B8","volume-title":"EMCDDA initial report on the new psychoactive substance 1-(3-chlorophenyl)-2-(methylamino)propan1-one (3-chloromethcathinone, 3-CMC)","year":"2021"},{"key":"B9","unstructured":"European Commission adopts measures to control two harmful new drugs amidst health concerns and surge in supply, EMCDDA, Lisbon, 18 March 2022"},{"key":"B10","unstructured":"European drug report 2020: Trends and developments2020"},{"key":"B11","unstructured":"European drug report 2022: Trends and developments"},{"key":"B12","unstructured":"New psychoactive substances: 25 years of early warning and response in Europe \u2014 An update from the EU early warning system"},{"key":"B13","unstructured":"Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920\/2006 (as amended)"},{"key":"B14","unstructured":"2014 annual report implementation council decision 2005\/387\/JHA2015"},{"key":"B15","unstructured":"EMCDDA\u2013EUROPOL 2016 annual report on the implementation of council decision2005\/387\/JHA2017"},{"key":"B16","first-page":"560","article-title":"In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin","volume":"28","author":"Fisher","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/METABO12020115","article-title":"In vitro metabolic study of four synthetic cathinones: 4-MPD, 2-NMC, 4F-PHP and bk-EPDP","volume":"12","author":"Gavrilovi\u0107","year":"2022","journal-title":"Metabolites"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2621","DOI":"10.1002\/HUP.2621","article-title":"Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone)","volume":"32","author":"Grifell","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/dta.1682","article-title":"Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS\/MS techniques and of its detectability by GC-MS or LC-MSn standard screening approaches","volume":"7","author":"Helfer","year":"2015","journal-title":"Drug Test. Anal."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1021\/ja01395a032","article-title":"Synthetic homologs of D,L-ephedrine","volume":"50","author":"Hyde","year":"1928","journal-title":"J. Am. Chem. Soc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00216-022-04440-6","article-title":"Synthesis of emerging cathinones and validation of a SPE GC-MS method for their simultaneous quantification in blood","volume":"415","author":"J\u00falio","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1021\/jo011042o","article-title":"Diminished reactivity of ortho-substituted phenacyl bromides toward nucleophilic displacement","volume":"68","author":"Kalendra","year":"2003","journal-title":"J. Org. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.podrm.2015.12.001","article-title":"Bupropion hydrochloride","volume":"41","author":"Khan","year":"2016","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/FTD.0000000000000808","article-title":"A review of synthetic cathinone-related fatalities from 2017 to 2020","volume":"43","author":"La Maida","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/J.TOXAC.2019.03.058","article-title":"Case report of a drug-related death following the use of cathinone derivatives (MPHP and 4-MEAP)","volume":"31","author":"Leli\u00e8vre","year":"2019","journal-title":"Toxicol. Anal. Clin."},{"key":"B26","doi-asserted-by":"publisher","first-page":"609251","DOI":"10.3389\/fchem.2020.609251","article-title":"Metabolic profile of four selected cathinones in microsome incubations: Identification of phase I and II metabolites by liquid chromatography high resolution mass spectrometry","volume":"8","author":"Lopes","year":"2021","journal-title":"Front. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/DTA.2355","article-title":"Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse","volume":"10","author":"Manier","year":"2018","journal-title":"Drug Test. Anal."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/metabo11010003","article-title":"Liquid chromatography-high-resolution mass spectrometry-based in vitro toxicometabolomics of the synthetic cathinones 4-MPD and 4-MEAP in pooled human liver microsomes","volume":"11","author":"Manier","year":"2020","journal-title":"Metabolites"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/J.FORSCIINT.2011.06.030","article-title":"The analysis of substituted cathinones. Part 2: An investigation into the phenylacetone based isomers of 4-methylmethcathinone and N-ethylcathinone","volume":"212","author":"McDermott","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/adt.2007.103","article-title":"An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion","volume":"6","author":"McNaney","year":"2008","journal-title":"Assay. Drug Dev. Technol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1021\/jm050797a","article-title":"1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors","volume":"49","author":"Meltzer","year":"2006","journal-title":"J. Med. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/jms.1859","article-title":"Studies on the metabolism of the \u03b1-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS","volume":"45","author":"Meyer","year":"2010","journal-title":"J. Mass Spectrom."},{"key":"B33","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2174\/138920010791526042","article-title":"Metabolism of designer drugs of abuse: An updated review","volume":"11","author":"Meyer","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/JMS.2960","article-title":"New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: Studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine","volume":"47","author":"Meyer","year":"2012","journal-title":"J. Mass Spectrom."},{"key":"B35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.forsciint.2016.06.034","article-title":"Identification and derivatization of selected cathinones by spectroscopic studies","volume":"266","author":"Nycz","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/ed077p1479","article-title":"A short, one-pot synthesis of bupropion (Zyban\u00ae, Wellbutrin\u00ae)","volume":"77","author":"Perrine","year":"2000","journal-title":"J. Chem. Educ."},{"key":"B37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1124\/dmd.114.061416","article-title":"Mass spectrometric evaluation of mephedrone in vivo human metabolism: Identification of phase i and phase II metabolites, including a novel succinyl conjugate","volume":"43","author":"Pozo","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"B38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jpba.2011.05.022","article-title":"Synthesis, full chemical characterisation and development of validated methods for the quantification of (\u00b1)-4\u2032-methylmethcathinone (mephedrone): A new \u00ablegal high","volume":"56","author":"Santali","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2478\/acph-2019-0024","article-title":"Metabolic stability and its role in the discovery of new chemical entities","volume":"69","author":"S\u0142oczy\u0144ska","year":"2019","journal-title":"Acta Pharm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/j.forsciint.2014.09.007","article-title":"Analysis and characterization of the novel psychoactive drug 4-chloromethcathinone (clephedrone)","volume":"244","author":"Taschwer","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/S11419-018-0427-8","article-title":"Blood concentrations of a new psychoactive substance 4-chloromethcathinone (4-CMC) determined in 15 forensic cases","volume":"36","author":"Tomczak","year":"2018","journal-title":"Forensic Toxicol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/jat\/bku021","article-title":"Testing for designer stimulants: Metabolic profiles of 16 synthetic cathinones excreted free in human urine","volume":"38","author":"Uralets","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/15563650.2016.1271132","article-title":"Misuse of 2-(ethylamino)-1-(4-methylphenyl)-1-pentanone (4-MEAP), a synthetic cathinone","volume":"55","author":"Varma","year":"2017","journal-title":"Clin. Toxicol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11419-019-00487-w","article-title":"Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone","volume":"38","author":"Wagmann","year":"2020","journal-title":"Forensic Toxicol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JCHROMB.2016.12.018","article-title":"Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS\/MS in case of severe intoxications","volume":"1041","author":"Wiergowski","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B46","volume-title":"Critical review report: 4-CMC (4-CHLOROMETHCATHIONE), expert committee on drug dependence forty-second meeting Geneva, 21-25 October 2019","year":"2019"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-78707-7_5","article-title":"Metabolism of synthetic cathinones","volume-title":"Synthetic cathinonesCurrent topics in neurotoxicity","author":"Zaitsu","year":"2018"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1145140\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T05:37:10Z","timestamp":1679636230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1145140\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":47,"alternative-id":["10.3389\/fphar.2023.1145140"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1145140","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"article-number":"1145140"}}